Cathy Eng, M.D., is the David H. Johnson Chair in surgical and medical oncology, director of the Vanderbilt-Ingram Cancer Center Young Adult Cancers Program, and a professor of medicine at Vanderbilt University Medical Center. Her primary clinical research interests include clinical trials involving innovative drugs for the treatment of colorectal, anal and appendiceal cancers.
August 20, 2021